are hosting an educational biosimilars webinar.
NON-MEDICAL SWITCHING OF BIOLOGICALS/BIOSIMILARS:
CANADA, EUROPE AND THE US
Overview of Non-Medical Switching Practices in Different Regions
and the Importance of Safeguarding the Physician–Patient Relationship
Wednesday, July 20, 2022 10:00 am – 12:00 pm (EDT)
The advent of biologicals offers significant benefits and enhanced quality of life for patients with chronic diseases, such as rheumatoid arthritis, multiple sclerosis, and cancer. However, finding a working treatment regimen may take a long time and involves trial and error for a patient’s individual case. Nevertheless, government policies that force biosimilar switching for non-medical and strictly economic reasons may ultimately affect patients’ treatment and their well-being, create mistrust in the healthcare system, undermine competition, increase total healthcare costs, and act as a barrier to innovation and future access to new biological drugs for patients.
Non-medical switching should consider two governing principles:
1) The physician-patient relationship must be protected to ensure the best outcomes.
2) Patients stabilized on a biological therapy should not be forced to undergo a non-medical switch.
Academic clinicians with specialties in oncology and ophthalmology, patient advocates, policymakers, and regulatory experts from Canada and the US will share their experience and knowledge on medical switching and principles and guidance on interchangeability of biologicals/biosimilars, highlighting the specific concerns on, and the importance of a multi-stakeholder approach protecting the physician-patient relationship in the practice of non-medical switching of biologicals/biosimilars. Improved information and protecting the physician-patient relationship in medical switching of biologicals/biosimilars will encourage smooth uptake of biosimilars.
Michael S Reilly, Esq, Executive Director, Alliance for Safe Biologic Medicines, USA
Gail Attara, President & Chief Executive Officer, Gastrointestinal Society, Canada
Ralph McKibbin, MD, FACP, FACG, AGAF, President of the Pennsylvania Society of
Gastroenterology and the Digestive Disease National Coalition, USA
Leah Christl, PhD, Amgen USA
Andrew Spiegel, Esq, Executive Director, Global Colon Cancer Association, USA
Retinal specialist/patient (to be advised), Canada
to keep up to date on the latest news and advocacy alerts.